Our Services
Medical Information
Helpful Resources
Published on: 3/12/2026
If SSRIs have not relieved your depression, you are not stuck; up to 30 to 50 percent need a different approach because depression often involves more than serotonin, including dopamine, norepinephrine, glutamate, inflammation, and other treatable contributors.
Medically approved next steps include switching to SNRIs or atypical antidepressants like bupropion or mirtazapine, adding low dose atypical antipsychotics, evidence-based therapies such as CBT, TMS, or ECT, and the newest class targeting glutamate, NMDA receptor antagonists like esketamine for treatment resistant cases. There are several factors to consider, including dosing, trial length, symptom patterns, and medical conditions, so see the complete guidance below before choosing your next step.
If you've taken an SSRI (selective serotonin reuptake inhibitor) and you're still depressed, you're not alone.
Up to 30–50% of people with major depressive disorder do not get full relief from their first antidepressant. Some feel slightly better but not "back to normal." Others feel no change at all.
This does not mean:
It usually means your brain needs a different strategy.
Let's break down why this happens — and what medically approved options are available now, including what is the newest class of antidepressants after SSRIs.
SSRIs (like sertraline, fluoxetine, escitalopram, and others) increase serotonin levels in the brain. For many people, that works. But depression is more complex than serotonin alone.
Here are common reasons SSRIs may not fully help:
Modern research shows depression involves:
If serotonin isn't your main issue, boosting it may not be enough.
Certain symptoms suggest other brain systems are involved:
Matching the treatment to your symptom pattern matters.
SSRIs typically take:
Some people need:
Stopping too early can make it seem like it "didn't work."
Treatment-resistant depression is usually defined as:
It sounds scary, but it simply means you need a different treatment approach, not that recovery is impossible.
If SSRIs haven't worked, you may be wondering:
What is the newest class of antidepressants after SSRIs?
The most significant newer development is:
These target the glutamate system, not serotonin.
This is one of the biggest breakthroughs in depression treatment in decades.
Unlike SSRIs, which slowly change serotonin levels, esketamine:
It is not a first-line treatment, but it is an option for people who haven't improved with standard antidepressants.
If you're still depressed, here are evidence-based options doctors consider.
Sometimes serotonin alone isn't enough.
Examples:
These affect both serotonin and norepinephrine. They may help more with:
These work differently than SSRIs.
Sometimes doctors:
This is common and evidence-based for partial responders.
FDA-approved add-on options include:
These affect dopamine and serotonin systems differently than SSRIs alone.
They're used in low doses for depression augmentation—not just psychosis.
As mentioned earlier, this represents one of the newest advances.
It may be considered if:
It requires supervised administration due to temporary dissociation or blood pressure changes.
If medication isn't enough, these are serious, evidence-based options:
If you're still depressed, your doctor may also check for:
Treating the underlying issue can change everything.
If you're feeling stuck:
Before your next doctor's appointment, consider using Ubie's free AI-powered Depression symptom checker to identify and organize your specific symptoms—it can help you have a more focused and productive conversation with your healthcare provider.
Depression can be stubborn.
Sometimes:
But here is the hopeful reality:
Most people who continue working with a provider do eventually find a treatment combination that works.
The key is persistence and personalization.
If you have:
This is urgent.
Speak to a doctor immediately or seek emergency care. Depression is treatable, but safety comes first.
If you're still depressed after SSRIs, your brain isn't "stuck forever." It likely needs a different approach.
Today's options go far beyond serotonin alone. The answer to "what is the newest class of antidepressants after SSRIs?" includes glutamate-modulating treatments like esketamine, which represent a major medical advance.
Other next steps include:
Depression treatment is no longer one-size-fits-all.
Speak to a doctor about your symptoms, especially if they are severe or life-threatening. The right treatment plan may simply be the next adjustment away.
(References)
* Duman, R. S., Aghajanian, G. K., Krystal, J. H., & Sanacora, G. (2016). Synaptic plasticity and the neurobiology of depression: a role for ketamine. Biological Psychiatry, 80(9), 717–726. https://pubmed.ncbi.nlm.nih.gov/27889122/
* Müller, M. K., & Tadic, A. (2020). Treatment-Resistant Depression: Definition, Neurobiology, Pharmacological Treatments, and Novel Treatment Options. Praxis (Bern, 1994), 109(10), 801–812. https://pubmed.ncbi.nlm.nih.gov/32906805/
* Kennedy, S. H., Dold, M., Avedisova, E., Blier, P., Demyttenaere, K., Eser, D., ... & Kasper, S. (2016). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder. Part 5: Additional Treatments and Considerations. The Canadian Journal of Psychiatry, 61(9), 561–576. https://pubmed.ncbi.nlm.nih.gov/28860086/
* Rodebaugh, T. L., & Hayes, R. A. (2021). The neurobiology of treatment-resistant depression. Neuroscience Letters, 750, 135760. https://pubmed.ncbi.nlm.nih.gov/33864703/
* Conklin, L. R., & Sutor, B. R. (2023). An Update on Treatment-Resistant Depression: Strategies and Emerging Therapies. The Primary Care Companion for CNS Disorders, 25(4), 22nr03478. https://pubmed.ncbi.nlm.nih.gov/37625129/
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.